A framework for pharmaceutical companies to develop a new value proposition for sales into medical group practices has been published by the Blue Spoon Consulting Group and is available for download through its web site (www.bluespoonconsulting.com). The approach positions a pharmaceutical component as the keystone to an entire ecosystem of businesses marketing to physicians, creating a value-added network to improve the service of health, the firm says.
There is an enduring "way of marketing" in the drug industry centered on promoting the features and benefits of brands. Commercial models are designed and, in turn, "optimized" to promotional response curves.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze